4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000027
Chief Operating Officer sold 100 shares at $15.01 ($1,501)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J Chief Operating Officer | 2022-09-15 | Sale | −100 | $15.01 | $1,501 | 68,648 | D: show line 1 in the form |
| Open-market sales · 100 sh · avg $15.01 · $1,501 | |||||||
Loading xslF345X03/wf-form4_166361963989994.xml…